Tower Research Capital (TRC)’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,847
| Closed | -$7K | – | 7092 |
|
|
2022
Q1 | $7K | Sell |
5,847
-211
| -3% | -$253 | ﹤0.01% | 4832 |
|
|
2021
Q4 | $7K | Buy |
6,058
+156
| +3% | +$180 | ﹤0.01% | 5000 |
|
|
2021
Q3 | $11K | Sell |
5,902
-2,672
| -31% | -$4.98K | ﹤0.01% | 4296 |
|
|
2021
Q2 | $20K | Sell |
8,574
-328
| -4% | -$765 | ﹤0.01% | 3918 |
|
|
2021
Q1 | $24K | Sell |
8,902
-5,991
| -40% | -$16.2K | ﹤0.01% | 3758 |
|
|
2020
Q4 | $36K | Buy |
14,893
+13,389
| +890% | +$32.4K | ﹤0.01% | 3440 |
|
|
2020
Q3 | $3K | Buy |
+1,504
| New | +$3K | ﹤0.01% | 4561 |
|
|
2019
Q3 | – | Sell |
-1,065
| Closed | -$4K | – | 4852 |
|
|
2019
Q2 | $4K | Buy |
+1,065
| New | +$4K | ﹤0.01% | 3099 |
|
|
2018
Q2 | – | Sell |
-523
| Closed | -$5K | – | 4350 |
|
|
2018
Q1 | $5K | Sell |
523
-93
| -15% | -$889 | ﹤0.01% | 2754 |
|
|
2017
Q4 | $6K | Sell |
616
-446
| -42% | -$4.34K | ﹤0.01% | 2845 |
|
|
2017
Q3 | $12K | Buy |
+1,062
| New | +$12K | ﹤0.01% | 3016 |
|
|
2017
Q1 | – | Sell |
-468
| Closed | -$15K | – | 4377 |
|
|
2016
Q4 | $15K | Buy |
468
+254
| +119% | +$8.14K | ﹤0.01% | 2391 |
|
|
2016
Q3 | $9K | Buy |
+214
| New | +$9K | ﹤0.01% | 2175 |
|
|
2016
Q1 | – | Sell |
-150
| Closed | -$6K | – | 5368 |
|
|
2015
Q4 | $6K | Sell |
150
-329
| -69% | -$13.2K | ﹤0.01% | 2871 |
|
|
2015
Q3 | $26K | Buy |
+479
| New | +$26K | ﹤0.01% | 1529 |
|
|
2015
Q2 | – | Sell |
-278
| Closed | -$26K | – | 5391 |
|
|
2015
Q1 | $26K | Buy |
278
+235
| +547% | +$22K | ﹤0.01% | 2051 |
|
|
2014
Q4 | $2K | Sell |
43
-725
| -94% | -$33.7K | ﹤0.01% | 3462 |
|
|
2014
Q3 | $56K | Buy |
+768
| New | +$56K | 0.01% | 1443 |
|
|
2014
Q2 | – | Sell |
-84
| Closed | -$12K | – | 4973 |
|
|
2014
Q1 | $12K | Buy |
+84
| New | +$12K | ﹤0.01% | 2463 |
|